Prediction and clinical utility of a contralateral breast cancer risk model. ...
BACKGROUND: Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the consequent burden of further treatment and potentially less favorable prognosis. We aimed to develop and validate a CBC risk prediction model and evaluate its applicability for clinical decision-making. METHODS: We included data of 132,756 invasive non-metastatic breast cancer patients from 20 studies with 4682 CBC events and a median follow-up of 8.8 years. We developed a multivariable Fine and Gray prediction model (PredictCBC-1A) including patient, primary tumor, and treatment characteristics and... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Scholarlyarticle |
Erscheinungsdatum: | 2019 |
Verlag/Hrsg.: |
Springer Science and Business Media LLC
|
Schlagwörter: | BRCA mutation carriers / Clinical decision-making / Contralateral breast cancer / Risk prediction model / Area Under Curve / BRCA1 Protein / BRCA2 Protein / Breast Neoplasms / Clinical Decision-Making / Disease Management / Disease Susceptibility / Female / Germ-Line Mutation / Humans / Neoplasms / Second Primary / Netherlands / Prognosis / Proportional Hazards Models / Risk Assessment / Risk Factors |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-29160447 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://dx.doi.org/10.17863/cam.48135 |